2012 Citizenship & Sustainability Report
Total Page：16
File Type：pdf, Size：1020Kb
2 012 Citizenship & Sustainability Report Contents About this Report ......................3 Environmental Impacts ................. 26 Culture of Health Program Global Reporting Initiative (GRI) ........3 Environmental, Health and Safety Provision and Innovation ........... 50 Feedback and Further Information .......3 Management Approach............... 26 Employee Health Goals .............. 50 Goal Setting ....................... 26 Lifestyle and Population Health ...... 51 Letter from the Chairman Organizational Responsibility .... 26 Mental Well-Being .................... 52 and Chief Executive Officer ..........4 Management Systems and Workplace Health Protection ........ 52 Successes & Challenges ..............6 Standards ........................ 27 Globally Harmonized Training ............................. 27 Health Policies .................... 52 Company Profile ........................9 Environmental Compliance ........... 27 Health Outcomes and Impacts ...... 53 Our Brands ................................9 Climate Change ....................... 27 Anti-Counterfeiting ...................... 53 Operational Structure ....................9 Climate Policy Initiatives ......... 27 Significant Changes During the Workplace Health and Safety .......... 53 Facility CO2 Emissions ........... 28 Reporting Period ..................... 10 Contractors ............................ 55 Transportation-Related Fleet Safety ........................... 55 Governance & External CO2 Emissions .................. 31 Commitments ......................... 10 Shipping-Related CO2 Employee and Labor Governance Structure .................. 10 Emissions ........................ 31 Relations Practices ..................... 57 Communication with Our Board ....... 12 Air Emissions .......................... 32 Workforce Statistics .................. 57 Codes & Principles ..................... 13 Green Buildings ....................... 32 Collective Bargaining ................. 58 Business Conduct Codes ............ 13 Water .................................. 32 Minimum Notice Periods ............. 58 Sales and Marketing .................. 13 Water Usage ....................... 32 Our Leadership Imperatives .......... 58 Labor and Employment ............... 13 Water Conservation ............... 33 Leadership Development ............. 59 Environment ........................... 13 Water Discharge .................. 34 Performance Management ........... 59 Pharmaceuticals in the External Commitments Skill and Talent Management .................. 13 Environment ..................... 34 and Training ......................... 60 Management Approach Waste Management .................. 35 Talent Attraction & Retention ........ 60 to Sustainability ...................... 14 Environmental Remediation ...... 35 Multiple Pathways for Career Sustainability Materiality Analysis Facilitiy Environmental Advancement ....................... 61 and Reporting Framework ........... 15 Transparency ........................ 36 Grievance Resolution ................. 61 Our Areas of Focus Biodiversity Conservation .............. 36 Optimizing Work, ................... 16 Family and Personal Life ........... 61 Quality & Safety of Products ........... 16 Product Stewardship & Design ........ 37 Benefits .................................. 61 Customer Health and Safety ......... 16 Business-Specific Initiatives ......... 40 Ingredient Safety ...................... 16 Packaging Improvements ............ 40 Diversity and Inclusion .................. 62 Product & Service Labeling .......... 16 Product Disposal ...................... 41 Employee Resource Groups ......... 63 Customer Satisfaction ................ 16 Stakeholder Engagement .............. 63 Marketing Communication ........... 16 Human Rights ........................... 41 Human Rights and Suppliers ......... 42 Selected Engagements and Privacy ................................. 17 Collaborations ...................... 63 Conflict Minerals ...................... 42 Compliance ............................ 17 Community ............................ 67 Global Health............................ 17 Transparency ............................ 43 Shareholders .......................... 68 Public Policy ........................... 44 Access to and Affordability of Global Policy Positions ........... 44 Managing Risk ........................ 70 Medicines ................................ 18 U.S. Policy Goals ................. 44 Risks Due to Climate Change ......... 70 Access to Medicines .................. 18 Our Participation with Trade Economic Performance ............. 71 Prescription Assistance Program .... 19 and Policy Development Corporate Contributions ............... 71 Pricing Strategies & Programs ....... 19 Organizations.................... 45 Economic Value Retained .............. 71 Access to HIV Medicines ............ 21 U.S. Trade Associations .......... 45 Defined Benefit Obligation ............. 72 Goals and Progress ................... 21 Political Contributions ............ 45 Governance & Oversight of Market Presence ........................ 72 Bioethics ................................. 22 Government Affairs Activities .. 46 Local Wages ............................ 72 Animal Testing......................... 22 Supply Chain ............................ 46 Supplier Spending ...................... 72 Stem Cells ............................. 23 Supplier Standards .................... 48 Hiring Practices ......................... 72 Nanotechnology ....................... 23 Supplier Diversity ..................... 48 Goals & Progress ..................... 73 Biotechnology ......................... 23 Emerging Markets....................... 48 Clinical Trials .......................... 23 Data Summary Table ................. 76 Model of Emerging Market Xenotransplantation .................. 23 Strategy ............................. 49 Recognitions .......................... 78 Innovation Wellness & Prevention ................................ 24 .................. 49 Global Reporting Index ............. 79 Live for Life™ Health Care Compliance and Ethics .. 25 .......................... 49 Our Credo .............................. 88 Anticorruption Training ............... 26 What is a Culture of Health? ......... 50 Johnson & Johnson 2012 Citizenship & sustainability ReporT · 2 Our rESPONSIBILITY Global Reporting Initiative (GRI) This report has been prepared consistent with the GRI’s 2006 About Sustainability Reporting Guidelines (G3.0 Guidelines), and we are self-declaring to Level A. A GRI Index is included, with This Report references to G3 indicators. This report has not been reviewed externally prior to publication. This report provides Johnson & Johnson’s citizenship and Feedback and Further Information sustainability activities and progress as of December 2012. It We invite you to comment on our sustainability activities and this is our 10th annual Citizenship & Sustainability Report and this report by emailing us at [email protected]. is our 16th year reporting environmental progress. The report is based on information from numerous sources, including socially responsible investment groups, nongovernmental organizations, multiple stakeholder engagements, senior company leadership input and comments, and feedback from our contact mailbox ([email protected]). Our 2012 reporting is presented in the Executive Summary of our Responsibility Report and in our full 2012 Responsibility Report (both available exclusively online). Additional information is available on our Citizenship & Sustainability website (www.jnj. com/responsibility). Our Executive Summary includes 2012 highlights and progress against our Healthy Future 2015 Goals. The 2012 Responsibility Report presents additional information on our goals and an update on our most material issues. The primary audience for these reports and our Citizenship & Sustainability website site are our external stakeholders, who are an extremely broad and diverse group. The Company has a variety of other mechanisms by which it shares citizenship and sustainability progress internally. Information presented in our reports and on our website is from the administration, research and development, manufacturing, marketing and selling organizations operated by the Johnson & Johnson Family of Companies, unless A Note About Locating GRI Indicators otherwise indicated. No external manufacturing is included In addition to a GRI index at the back of this report, we in our data, except as indicated in this report. As we engage have provided a guide box on each page to denote where further with our supply chain on citizenship and sustainability content related to specific GRI indicators can be found. topics, additional information on these efforts will continue to The following key presents two-letter abbreviations for the be incorporated into our reports. There have been no significant standard disclosure areas outlined by the Global Reporting changes from previous reporting periods in the scope, boundary Initiative. These abbreviations, along with numbers that or measurement methods applied in this report. Acquisitions and correspond with performance divestitures are discussed under the Company Profile section of indicators, appear throughout this this report. report near the respective entries. EN Environmental HR Human Rights LA Labor Practices and Decent Work ON the COVer SO Society A “corporate athlete” course changed Pablo C. Vega’s life PR Product Responsibility